动态增强磁共振定量参数联合表观扩散系数值评估宫颈癌同步放化疗效果的价值

Value of quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient value in evaluating the efficacy of synchronous radiotherapy and chemotherapy in cervical cancer patients

  • 摘要: 目的 探讨动态增强磁共振(DCM-MRI)定量参数联合表观扩散系数(ADC)值评估宫颈癌同步放化疗效果的价值。 方法 选取88例宫颈癌患者,均行同步放化疗,比较患者治疗前与治疗结束时肿瘤DCE-MRI定量参数,并观察ADC值。 结果 治疗后,宫颈癌患者肿瘤体积小于治疗前, ADC值高于治疗前,差异均有统计学意义(P<0.05)。治疗后,宫颈癌患者对比剂从血浆间隙渗漏到血管外细胞外间隙的转移系数(Ktrans)、血管外细胞外间隙容积分数(Ve)高于治疗前,差异有统计学意义(P<0.05), 而对比剂从血管外细胞外间隙返回血浆间隙的速率常数(Kep)、血浆间隙容积分数(Vp)与治疗前比较,差异无统计学意义(P>0.05)。 结论 DCM-MRI定量参数联合ADC值能较好地评估宫颈癌同步放化疗效果,可作为常规评估宫颈癌放化疗效果的方法。

     

    Abstract: Objective To evaluate the value of quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging(DCM-MRI)combined with apparent diffusion coefficient(ADC)value in evaluating the efficacy of synchronous radiotherapy and chemotherapy in patients with cervical cancer. Methods A total of 88 cervical cancer patients were selected, and underwent synchronous radiotherapy and chemotherapy, and DCE-MRI examination was carried out before and after treatment. Quantitative parameters of tumor DCE-MRI before and after treatment were measured and analyzed, and ADC values were observed. Results The tumor volume after cervical cancer treatment was significantly smaller than treatment before(P<0.05), ADC value after treatment was significantly higher than treatment before(P<0.05). After treatment, volume transfer coefficient(Ktrans)and extravascular extracellular space volume fraction(Ve)of contrast agent leakage from plasma to extracellular spaces in patients with cervical cancer were significantly higher than those before treatment(P<0.05), while rate constant between extravascular extracellular space and blood plasma(Kep)and fractional blood plasma volume(Vp)showed no significant differences compared to pre-treatment(P>0.05). Conclusion Quantitative parameters of DCM-MRI combined with ADC value can better evaluate the effect of synchronous radiotherapy and chemotherapy of cervical cancer, which can be used as - a routine examination to evaluate the efficacy of radiotherapy and chemotherapy of cervical cancer.

     

/

返回文章
返回